<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of endogenous extracellular <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (EC-SOD) was examined in a murine model of transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Homozygous EC-SOD deficient (EC-SOD-/-; n = 18) and <z:mp ids='MP_0002169'>wild type</z:mp> (EC-SOD+/+; n = 19) littermates were anesthetized with <z:chebi fb="2" ids="5615">halothane</z:chebi> and subjected to 50 min of intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> with pericranial temperature maintained at 37.0 degrees C </plain></SENT>
<SENT sid="2" pm="."><plain>After 24 h of reperfusion, resultant <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> and cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size were measured </plain></SENT>
<SENT sid="3" pm="."><plain>Total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was 81% greater (P = 0.03) and <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> was more severe (P = 0.01) in EC-SOD-/- versus EC-SOD+/+ mice </plain></SENT>
<SENT sid="4" pm="."><plain>The worsened ischemic outcome observed in EC-SOD-/- mice is consistent with prior work which found transgenic EC-SOD overexpressing mice to exhibit enhanced tolerance to focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The results suggest that endogenous <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity in the extracellular compartment plays an important role in the histologic/neurologic response to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>